ANLONG BIO
Anlong Bio focuses on the research and development of nucleic acid drugs, including gene therapy, RNA drugs, and gene editing. The core team has experience in domestic and foreign scientific research, multinational pharmaceutical companies, entrepreneurship, and investment. In the fields with huge market potential, the varieties of independent intellectual property rights are developed, and most of them are at the forefront of the country. In the field of rare diseases, they use the rich resourc... es of rare disease patients in China to actively cooperate with foreign companies. The company aims to provide various genetic medicines to fulfill the unmet medical need in China, they develop AAV gene therapies with in-house technologies from vector discoveries to manufacturing and clinical approval.
ANLONG BIO
Social Links:
Industry:
Genetics Health Care Medical Pharmaceutical Therapeutics
Founded:
2019-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.anlongbio.com
Total Employee:
51+
Status:
Active
Contact:
86-10-80414166
Email Addresses:
[email protected]
Similar Organizations
ANLBIO
ANLBIO is a researcher and developer of adeno-associated virus-based gene therapy products.
Cell Products of National Engineering Research Center
Cell Products of National Engineering Research Center engages in the research and development of cell therapeutic products.
Ever Supreme Bio Technology
Ever Supreme Bio Technology is engaged in the research and development of cell gene therapies
Evergreen Therapeutics
Evergreen Therapeutics engages in the research and development of clinical drugs in the field of immunity and ophthalmology.
Haina Pharmaceuticals
Haina Pharmaceuticals engages in the research and development of drugs, biological sample testing, and drug registration.
Tyercan
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
Current Employees Featured
Investors List
TaiKun Fund
TaiKun Fund investment in Series A - Anlong Bio
Shunchuang Industrial Investment Management Fund
Shunchuang Industrial Investment Management Fund investment in Series A - Anlong Bio
Official Site Inspections
http://www.anlongbio.com Semrush global rank: 12.95 M Semrush visits lastest month: 78
- Host name: 39.106.83.110
- IP address: 39.106.83.110
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Anlong Bio"
首页
2019 安龙生物于2019年由著名投资人和企业家赵春林博士创立。赵春林博士对医疗保健和生命科学充满热情,并在三个基金中拥有丰富的经验,其中包括作为我们主要合作伙伴之一的安龙基金的创始人。See details»
Anlong Bio - Crunchbase Company Profile & Funding
Anlong Bio focuses on the research and development of nucleic acid drugs, including gene therapy, RNA drugs, and gene editing.See details»
AnLong Bio - Company Profile & Staff Directory | ContactOut
At Anlong Bio, patients are our priority. Since launching, our goal has been to deliver transformative gene therapy medicines to patients faster and at low cost, in China and …See details»
AnLong Bio Overview | SignalHire Company Profile
Anlong Bio focuses on the research and development of nucleic acid drugs, including gene therapy, RNA drugs, and gene editing. The core team has experience in domestic and foreign …See details»
Zhongguancun – Anlongbio – Genetic Medicine in China
Meanwhile, Anlong Bio has integrated abundant rare disease resources in China. It has built a close relationship with the nation's largest rare disease organization,the Chinese Organization for Rare Disorders, to lay the …See details»
Anlong Bio - VentureRadar
"AnlongBio aims to provide various genetic medicines to fulfill the unmet medical need in China, we develop AAV gene therapies with in-house technologies from vector discoveries to …See details»
AnLong Bio - Biotechnology - Overview, Competitors, and
At Anlong Bio, patients are our priority. Since launching, our goal has been to deliver transformative gene therapy medicines to patients faster and at low cost, in China and …See details»
AnlongBio - PitchBook
Information on valuation, funding, cap tables, investors, and executives for AnlongBio. Use the PitchBook Platform to explore the full profile.See details»
Beijing Anlong Biomedical Co., Ltd. - synapse.zhihuiya.com
了解Beijing Anlong Biomedical Co., Ltd. (北京安龙生物医药有限公司)公司的药物管线,治疗领域,技术平台,以及它的2项临床试验, 49篇新闻,疾病领域:感染,技术平台:腺相关病毒基因治 …See details»
北京安龙生物医药有限公司 - 企查查
Feb 3, 2024 简介:北京安龙生物医药有限公司(曾用名:北京安龙基因医药技术有限公司)是⼀家成⽴于2019年08月09日的其他有限责任公司,也是安龙生物旗下企业,属于以从事制造业 …See details»
Corporate culture – Anlongbio – Genetic Medicine in China
At Anlong Bio, we are motivated problem solvers who believe that whatwe do matters. Our culture is driven by finding solutions and fosteringcollaboration to succeed together. This allows us to …See details»
AnLong Bio - LinkedIn
AnLong Bio | 135 followers on LinkedIn. Advancing Transformative Genetic Medicines for Patients | At Anlong Bio, patients are our priority. Since launching, our goal has been to deliver ...See details»
Anlong - Products, Competitors, Financials, Employees, …
Anlong Unclaimed anlongbio.com Overview & Products Financials Founded Year 2019 Stage Series A - II | Alive Mosaic Score +68 points in the past 30 daysSee details»
Patrick Soon-Shiong - Wikipedia
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, and transplant surgeon. He is the inventor of the drug Abraxane, which is …See details»
Investors – Anlongbio – Genetic Medicine in China
Tigermed, a pioneer clinical Contract Research Organization (CRO) in China, dedicated to providing new drug research and clinical development services to global and Chinese …See details»
Anlong Bio Announces $30 Million Series A Funding led by
Aug 31, 2021 On June 9th, 2021, Anlong Biopharmaceutical Co., Ltd (AnlongBio), a genetic medicine company in China, announced that it had completed a $30 Million Series A funding …See details»
AnLong Bio on LinkedIn: Anlong Bio Founder and CEO Adam Zhao ...
Anlong Bio Founder and CEO Adam Zhao participate MSQ Ventures's 2021 Cross-Border Healthcare Innovation & Partnership Summit to discuss opportunities for…See details»
Zhongguancun – Anlongbio – Genetic Medicine in China
BEIJING, Sep 29,2021 — Anlong Biopharmaceutical Co., Ltd (AnlongBio),a gene therapy company in China, announced the appointment of Long Jiang, MD as chief medical officer …See details»
Company News – Anlongbio – Genetic Medicine in China
Anlong Bio Announces $30 Million Series A Funding led by CITIC Medical Fund On June 9th, 2021, Anlong Biopharmaceutical Co.,Ltd (AnlongBio), genetic therapygene therapy company …See details»